Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

ClinicalTrials.gov ID: NCT02598934

Public ClinicalTrials.gov record NCT02598934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Open-Label, Multicenter Study to Evaluate the Change in Bone Turnover Markers After Once Monthly Oral Ibandronate Therapy in Treatment Naive Postmenopausal Osteoporosis Patients

Study identification

NCT ID
NCT02598934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
308 participants

Conditions and interventions

Interventions

  • Ibandronate Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2004
Primary completion
Apr 30, 2006
Completion
Apr 30, 2006
Last update posted
Mar 8, 2016

2004 – 2006

United States locations

U.S. sites
50
U.S. states
26
U.S. cities
49
Facility City State ZIP Site status
Not listed Montgomery Alabama 36111
Not listed Chandler Arizona 85225
Not listed Peoria Arizona 85381
Not listed Hot Springs Arkansas 71913
Not listed Pine Bluff Arkansas 71603
Not listed Anaheim California 92801
Not listed Beverly Hills California 90211
Not listed Carmichael California 95608
Not listed Wilmington Delaware 19805
Not listed DeLand Florida 32720
Not listed Miami Florida 33176
Not listed Miami Florida 33186
Not listed Palm Habor Florida 34684
Not listed Palm Springs Florida 33461
Not listed West Palm Beach Florida 33409
Not listed Atlanta Georgia 30309
Not listed Rome Georgia 30165
Not listed Morton Grove Illinois 60053
Not listed Indianapolis Indiana 46202
Not listed Waterloo Iowa 50702
Not listed Baltimore Maryland 21209
Not listed Hagerstown Maryland 21740
Not listed Reistertown Maryland 21136
Not listed Olive Branch Mississippi 38654
Not listed Jefferson City Missouri 65109
Not listed St Louis Missouri 63108
Not listed Omaha Nebraska 68131
Not listed Bloomfield New Jersey 07003
Not listed New York New York 10016
Not listed The Bronx New York 10461
Not listed Morehead City North Carolina 28557
Not listed Morganton North Carolina 28655
Not listed Raleigh North Carolina 27612
Not listed Oklahoma City Oklahoma 73112
Not listed Medford Oregon 97504
Not listed Doylestown Pennsylvania 18901
Not listed Langhorne Pennsylvania 19047
Not listed Philadelphia Pennsylvania 19131
Not listed Mt. Pleasant South Carolina 29464
Not listed Spartanburg South Carolina 29307
Not listed Morristown Tennessee 37813
Not listed Murfreesboro Tennessee 37130
Not listed Nashville Tennessee 37203
Not listed Amarillo Texas 79106
Not listed Fort Worth Texas 76101
Not listed San Antonio Texas 78229
Not listed Texarkana Texas 75503
Not listed Richmond Virginia 23226
Not listed Tacoma Washington 98405
Not listed Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02598934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2016 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02598934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →